Liu Jinxiang, Zhang Jiaying, Gao Yang, Jiang Yuxuan, Guan Zhenxin, Xie Yiying, Hu Jinghui, Chen Jing
School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University, Yantai, 264003, PR China.
School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University, Yantai, 264003, PR China; School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, 210023, PR China.
Cancer Lett. 2023 May 28;562:216166. doi: 10.1016/j.canlet.2023.216166. Epub 2023 Apr 5.
Nanomedicines can effectively penetrate tumor sites compared to traditionally used drugs. However, effective drugs that reach the interior of tumors remain limited. Based on studies of the complex tumor microenvironment, we summarized the barriers restricting tumor penetration of nanomedicines in this review. Penetration barriers are mainly caused by tumor blood vessels, stroma, and cell abnormalities. The repair of abnormal tumor blood vessels and tumor stroma and adjusting the physicochemical properties of nanoparticles are considered promising strategies to improve the tumor permeation of nanomedicines. The effects of nanoparticle properties, including size, shape, and surface charge, on tumor penetration were also reviewed. We expect to provide research ideas and a scientific basis for nanomedicines to increase intratumoral permeability and improve anti-tumor effects.
与传统使用的药物相比,纳米药物能够有效地穿透肿瘤部位。然而,能够到达肿瘤内部的有效药物仍然有限。基于对复杂肿瘤微环境的研究,我们在本综述中总结了限制纳米药物肿瘤穿透的障碍。穿透障碍主要由肿瘤血管、基质和细胞异常引起。修复异常的肿瘤血管和肿瘤基质以及调整纳米颗粒的物理化学性质被认为是提高纳米药物肿瘤渗透的有前景的策略。还综述了纳米颗粒性质(包括大小、形状和表面电荷)对肿瘤穿透的影响。我们期望为纳米药物增加肿瘤内渗透性和提高抗肿瘤效果提供研究思路和科学依据。
Cancer Lett. 2023-5-28
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018-4-16
Adv Healthc Mater. 2022-1
Biomacromolecules. 2017-5-8
Chem Rev. 2023-9-27
Yao Xue Xue Bao. 2016-2
Curr Clin Pharmacol. 2018
Pharmaceuticals (Basel). 2025-7-22
Pharmaceuticals (Basel). 2025-6-18
Int J Nanomedicine. 2024
Front Bioeng Biotechnol. 2023-8-16